Table 2.

Adjusted hazard ratios with 95% confidence intervals for cardiovascular recurrence and all cause mortality after myocardial infarction in the community, 1993-2001

	All cause mortality			Non-fatal myocardial infarction or death from cardiovascular disease
Predictor	Overall	Women	Older people	Overall	Women	Older people
Sex (male v female)	1.19 (1.07 to 1.33)	to	1.15 (1.03 to 1.29)	1.11 (1.00 to 1.24)	to	1.11 (0.99 to 1.25)
Age:
<45	1.00	1.00	to	1.00	1.00	—
45-54	0.96 (0.48 to 1.94)	1.40 (0.18 to 11.24)		0.99 (0.60 to 1.61)	0.55 (0.19 to 1.53)
55-64	1.58 (0.83 to 3.02)	2.91 (0.40 to 21.37)		1.26 (0.79 to 2.00)	0.79 (0.31 to 2.02)
65-74	2.57 (1.36 to 4.84)	3.26 (0.45 to 23.59)		1.59 (1.01 to 2.51)	0.79 (0.32 to 1.99)
≥75	3.57 (1.90 to 6.73)	4.50 (0.62 to 32.50)		1.90 (1.20 to 2.99)	0.95 (0.38 to 2.38)
Deprivation category:
1 (least deprived)	1.00	1.00	1.00	1.00	1.00	1.00
2	1.13 (0.89 to 1.43)	0.93 (0.66 to 1.32)	1.10 (0.86 to 1.40)	1.14 (0.90 to 1.43	0.88 (0.62 to 1.24)	1.04 (0.81 to 0.34)
3	1.18 (0.95 to 1.48)	0.92 (0.65 to 1.29)	1.19 (0.95 to 1.50)	1.12 (0.90 to 1.39	0.75 (0.53 to 1.06)	1.06 (0.84 to 1.35)
4	1.37 (1.09 to 1.72)	1.13 (0.81 to 1.59)	1.30 (1.03 to 1.66)	1.24 (0.99 to 1.56	0.92 (0.65 to 1.30)	1.13 (0.88 to 1.44)
5	1.39 (1.09 to 1.78)	1.03 (0.70 to 1.50)	1.29 (1.00 to 1.68)	1.34 (1.06 to 1.71)	0.92 (0.63 to 1.36)	1.15 (0.88 to 1.50)
6 (most deprived)	1.27 (1.01 to 1.60)	0.97 (0.68 to 1.37)	1.24 (0.97 to 1.58)	1.21 (0.97 to 1.52)	0.86 (0.60 to 1.21)	1.12 (0.88 to 1.44)
Statins	0.69 (0.59 to 0.80)	0.63 (0.49 to 0.80)	0.72 (0.61 to 0.84)	0.82 (0.71 to 0.95)	0.69 (0.54 to 0.88)	0.84 (0.71 to 0.99)
β blockers	0.38 (0.33 to 0.43)	0.46 (0.37 to 0.56)	0.39 (0.34 to 0.45)	0.40 (0.35 to 0.46)	0.48 (0.39 to 0.59)	0.46 (0.40 to 0.53)
Angiotensin converting enzyme inhibitors	0.54 (0.48 to 0.61)	0.55 (0.45 to 0.66)	0.56 (0.50 to 0.64)	0.57 (0.50 to 0.64)	0.64 (0.53 to 0.78)	0.61 (0.54 to 0.70)
Nitrates	0.68 (0.61 to 0.77)	0.68 (0.57 to 0.82)	0.66 (0.58 to 0.75)	0.78 (0.69 to 0.88)	0.78 (0.65 to 0.94)	0.75 (0.65 to 0.85)
Calcium blockers	0.76 (0.67 to 0.86)	0.74 (0.61 to 0.89)	0.73 (0.65 to 0.83)	0.79 (0.70 to 0.89)	0.75 (0.62 to 0.91)	0.76 (0.66 to 0.87)
Antihypertensive drugs	1.14 (1.01 to 1.29)	0.83 (0.70 to 0.99)	1.13 (1.00 to 1.28)	0.90 (0.80 to 1.02)	0.72 (0.60 to 0.86)	0.91 (0.80 to 1.03)
Antiplatelet drugs	0.44 (0.39 to 0.50)	0.49 (0.41 to 0.58)	0.41 (0.36 to 0.47)	0.42 (0.37 to 0.47)	0.44 (0.37 to 0.53)	0.39 (0.34 to 0.45)
Warfarin	0.97 (0.84 to 1.14)	0.94 (0.74 to 1.20)	0.89 (0.75-1.06)	0.93 (0.78 to 1.10)	0.84 (0.64 to 1.09)	0.86 (0.71 to 1.04)

Other covariates included in the multivariate analysis: non-steroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, hormone replacement therapy, and oral contraceptives, steroids, previous cardiovascular disease, and comorbidity (diabetes, obstructive airway disease, cancer, renal failure, rheumatoid arthritis).